{"id":"https://openalex.org/W2739835489","doi":"https://doi.org/10.1158/1538-7445.am2017-5197","title":"Abstract 5197: Targeting PARP-1 to deliver alpha-particles to cancer chromatin","display_name":"Abstract 5197: Targeting PARP-1 to deliver alpha-particles to cancer chromatin","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2739835489","doi":"https://doi.org/10.1158/1538-7445.am2017-5197","mag":"2739835489"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-5197","doi":"https://doi.org/10.1158/1538-7445.am2017-5197","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5197","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069923599","display_name":"Laura N. Puentes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Puentes","raw_affiliation_strings":["1University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102379498","display_name":"Kuiying Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kuiying Xu","raw_affiliation_strings":["1University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082627212","display_name":"Catherine Hou","orcid":"https://orcid.org/0000-0001-8905-8492","observed_orcids":["https://orcid.org/0000-0001-8905-8492"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Hou","raw_affiliation_strings":["1University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013971949","display_name":"Robert H. Mach","orcid":"https://orcid.org/0000-0002-7645-2869","observed_orcids":["https://orcid.org/0000-0002-7645-2869"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert H. Mach","raw_affiliation_strings":["1University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005797590","display_name":"John M. Maris","orcid":"https://orcid.org/0000-0002-8088-7929","observed_orcids":["https://orcid.org/0000-0002-8088-7929"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Maris","raw_affiliation_strings":["2Children's Hospital of Philadelphia, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Children's Hospital of Philadelphia, Philadelphia, PA","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074054064","display_name":"Daniel A. Pryma","orcid":"https://orcid.org/0000-0001-8978-4419","observed_orcids":["https://orcid.org/0000-0001-8978-4419"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Pryma","raw_affiliation_strings":["1University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071268972","display_name":"Mehran Makvandi","orcid":"https://orcid.org/0000-0002-6315-4942","observed_orcids":["https://orcid.org/0000-0002-6315-4942"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehran Makvandi","raw_affiliation_strings":["1University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"5197","last_page":"5197"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11359","display_name":"Effects of Radiation Exposure","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.8100000023841858},{"id":"https://openalex.org/keywords/alpha-particle-therapy","display_name":"alpha therapy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.871999979019165},{"id":"https://openalex.org/keywords/alpha-emitting-radionuclide","display_name":"alpha-emitting radionuclide","score":0.6890000104904175},{"id":"https://openalex.org/keywords/targeted-alpha-therapy","display_name":"targeted alpha therapy","score":0.5630000233650208},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.8820000290870667},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6209999918937683},{"id":"https://openalex.org/keywords/tumor-biodistribution","display_name":"tumor biodistribution","score":0.7229999899864197},{"id":"https://openalex.org/keywords/high-risk-neuroblastoma","display_name":"high-risk neuroblastoma","score":0.7329999804496765},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.628000020980835},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.37400001287460327},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6417493224143982},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5835459232330322},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.5294049978256226},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5287613272666931},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4913462698459625},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4570569694042206},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4498049318790436},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44425514340400696},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.43187713623046875},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38268202543258667},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37355464696884155},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3621629476547241},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.35504233837127686},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3432527184486389},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29908204078674316},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2088407576084137},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18023964762687683},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.15781709551811218},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11377647519111633},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.10446891188621521}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-5197","doi":"https://doi.org/10.1158/1538-7445.am2017-5197","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5197","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2605277220","https://openalex.org/W4249552652","https://openalex.org/W2953498124","https://openalex.org/W2944791611","https://openalex.org/W4309235602","https://openalex.org/W2490739915","https://openalex.org/W4239325545","https://openalex.org/W4245472206","https://openalex.org/W2750605024","https://openalex.org/W3007444207"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Neuroblastoma":[2],"(NB)":[3],"is":[4,27,42,331],"a":[5,30,57,88,99,121,217,246,278,332,376],"radiosensitive":[6],"pediatric":[7],"cancer":[8,349,408],"that":[9,75,93,336],"develops":[10],"in":[11,44,77,111,120,160,203,220,249,323,326,342,348],"the":[12,21,95,106,130,235,364,370,414],"sympathetic":[13],"nervous":[14],"system":[15],"and":[16,61,148,164,199,252,267,292,321,344,362],"typically":[17],"affects":[18],"children":[19],"under":[20],"age":[22],"of":[23,82,98,109,123,133,187,237,258,300,354,366,373,413],"10.":[24],"High-risk":[25],"NB":[26,125,228],"associated":[28],"with":[29,105],"40%":[31],"5-year":[32],"survival":[33],"rate.":[34],"Nuclear":[35],"enzyme":[36],"poly":[37],"(ADP-ribose)":[38],"polymerase":[39],"1":[40,265],"(PARP-1)":[41],"overexpressed":[43],"high-risk":[45,112,124,381],"NB,":[46],"making":[47],"it":[48],"an":[49],"attractive":[50],"target":[51],"for":[52,196,225,380,417],"alpha-particle":[53],"therapy.":[54,206],"Alpha-particles":[55],"have":[56,356],"short":[58],"path":[59],"length":[60],"high":[62],"linear":[63],"energy":[64],"transfer,":[65],"causing":[66],"dense":[67],"ionizations":[68],"across":[69],"DNA,":[70],"inducing":[71],"double":[72],"stranded":[73],"breaks":[74,347],"result":[76],"cell":[78,126,221,229],"death.":[79],"The":[80,184,255,351],"purpose":[81],"this":[83],"study":[84],"was":[85,118,138,158,167,175,189,201],"to":[86,128,162,169,179,205,239,404,407],"explore":[87],"newly":[89],"developed":[90],"radiotherapeutic":[91,335],"([211At]MM4)":[92],"combines":[94],"targeting":[96,263],"potential":[97,372],"small":[100],"molecule":[101],"PARP":[102],"inhibitor":[103],"(PARPi)":[104],"cytotoxic":[107,352],"effects":[108,353],"211At":[110],"NB.":[113],"Methods:":[114],"In":[115,154],"vitro":[116],"cytotoxicity":[117],"performed":[119,176,190,202],"panel":[122],"lines":[127],"evaluate":[129],"relative":[131],"potency":[132],"[211At]MM4.":[134],"Next,":[135],"DNA":[136,287],"damage":[137,288],"assessed":[139],"by":[140,290],"measuring":[141],"gH2AX":[142,251,291],"foci":[143],"formation":[144],"at":[145,264,272],"1,":[146],"4,":[147],"24":[149],"hrs":[150],"after":[151,177,306],"[211At]MM4":[152,188,259,330,355,374],"treatment.":[153,297],"parallel,":[155],"PARP-1":[156,166,253,293,340,403],"expression":[157,294],"measured":[159,289],"response":[161,204],"therapy":[163,181,209,312],"cleaved":[165],"quantified":[168],"assess":[170],"apoptosis.":[171],"Cell":[172],"cycle":[173],"analysis":[174,244],"treatment":[178,224,307,378],"identify":[180],"related":[182],"effects.":[183],"in-vivo":[185,208,256],"biodistribution":[186,257],"alongside":[191],"ex-vivo":[192],"autoradiography.":[193],"Tumor":[194,284],"cytology":[195,285],"PARP-1,":[197],"gH2AX,":[198],"Ki-67":[200,309],"Finally,":[207],"experiments":[210,368],"were":[211,304,319],"performed.":[212],"Results:":[213],"Cytotoxicity":[214],"data":[215],"indicated":[216],"significant":[218,324],"reduction":[219],"viability":[222],"following":[223,296],"all":[226,270],"six":[227],"lines,":[230],"in-vitro":[231,361],"co-incubation":[232],"studies":[233,314],"confirmed":[234],"specificity":[236],"[211At]-MM4":[238],"its":[240],"drug":[241],"target.":[242],"Immunofluorescence":[243],"showed":[245,277],"dose-dependent":[247],"increase":[248],"both":[250,360],"expression.":[254],"revealed":[260,286,315],"rapid":[261],"tumor":[262,302,327],"hr":[266],"clearance":[268],"from":[269],"tissues":[271],"4":[273],"hrs.":[274],"Ex-vivo":[275],"autoradiography":[276],"tumor-muscle":[279],"ratio":[280],"greater":[281],"than":[282],"6.":[283],"increased":[295],"Small":[298],"colonies":[299],"proliferating":[301],"cells":[303],"detected":[305],"using":[308],"staining.":[310],"In-vivo":[311],"efficacy":[313],"low":[316],"fractionated":[317],"doses":[318],"tolerable":[320],"resulted":[322],"delay":[325],"regrowth.":[328],"Conclusion:":[329],"novel":[333],"alpha-emitting":[334],"specifically":[337],"targets":[338],"nuclear":[339],"overexpression":[341],"neuroblastoma":[343],"incites":[345],"double-stranded":[346],"DNA.":[350],"been":[357],"experimentally":[358],"validated":[359],"in-vivo;":[363],"results":[365],"these":[367],"confirm":[369],"therapeutic":[371],"as":[375],"viable":[377],"option":[379],"neuroblastoma.":[382],"Citation":[383],"Format:":[384],"Laura":[385],"Puentes,":[386],"Kuiying":[387],"Xu,":[388],"Catherine":[389],"Hou,":[390],"Robert":[391],"H.":[392],"Mach,":[393],"John":[394],"M.":[395],"Maris,":[396],"Daniel":[397],"A.":[398],"Pryma,":[399],"Mehran":[400],"Makvandi.":[401],"Targeting":[402],"deliver":[405],"alpha-particles":[406],"chromatin":[409],"[abstract].":[410],"In:":[411],"Proceedings":[412],"American":[415],"Association":[416],"Cancer":[418,431],"Research":[419],"Annual":[420],"Meeting":[421],"2017;":[422],"2017":[423],"Apr":[424],"1-5;":[425],"Washington,":[426],"DC.":[427],"Philadelphia":[428],"(PA):":[429],"AACR;":[430],"Res":[432],"2017;77(13":[433],"Suppl):Abstract":[434],"nr":[435],"5197.":[436],"doi:10.1158/1538-7445.AM2017-5197":[437]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2017-08-08T00:00:00"}